Attività
Numero di dipendenti: 57
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 01/05/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 63 331 613 | 36 906 514 ( 58,28 %) | 1 319 857 ( 2,084 %) | 58,28 % |
Coordinate società
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
![Indirizzo Pardes Biosciences, Inc.(PRDS)](https://cdn.zonebourse.com/static/address/131203376.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+22,10% | 46,55 Mrd | |
+46,45% | 41,84 Mrd | |
-3,12% | 40,84 Mrd | |
+36,10% | 32,95 Mrd | |
-6,30% | 28,27 Mrd | |
+18,71% | 27,78 Mrd | |
+46,15% | 14,26 Mrd | |
+44,52% | 13,69 Mrd | |
+0,19% | 12,18 Mrd |